The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
"We are delighted for the Company to be able to conclude the TSP process. We exit the TSP on a far stronger financial footing than when we entered, thanks to the encouraging customer contracts and the fundraise we undertook in December. Ethernity is well positioned for further growth and to capitalise on its market leading solutions. I would like to thank our customers, suppliers, shareholders and employees for their ongoing support of the business and look forward to 2024 with confidence."
Excellent short,med & long term hold